Experience with teicoplanin in the treatment of neonatal staphylococcal sepsis

Journal of International Medical Research

Volumn 32, Issue 5, 2004, Pages 540-548

  Yalaz, M ^a   Cetin, H ^a   Akisu, M ^a   Yeniay, B ^a   Tunger, A ^a   Kultursay, N ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Neonatal; Newborn; Sepsis; Staphylococcal infection; Teicoplanin

Indexed keywords

AMINOGLYCOSIDE; ANTIFUNGAL AGENT; CARBAPENEM; CLINDAMYCIN; COLONY STIMULATING FACTOR; GENTAMICIN; GLYCOPEPTIDE; IMMUNOGLOBULIN; METICILLIN; SULTAMICILLIN; TEICOPLANIN; VANCOMYCIN;

ABSCESS; ANAPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; ERADICATION THERAPY; FEMALE; GESTATIONAL AGE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; NEWBORN; NEWBORN SEPSIS; OTOTOXICITY; PENICILLIN RESISTANCE; PHLEBITIS; SEPTICEMIA; SIDE EFFECT; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 4544265824     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200512     Document Type: Article

References (25)

1. Berger A, Salzer HR, Weninger M, Sageder B, Aspock C: Septicaemia in an Austrian neonatal intensive care unit: a 7-year analysis. Acta Paediatr 1998; 87: 1066-1069.
2. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al: Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291.
3. Cole FS: Bacterial infections of the newborn. In: Avery's Disease of the Newborn, 7th edn. (Taeusch HW, Ballard RA, eds). Pennsylvania: WB Saunders Company, 1998; pp490-513.
4. Fanos V, Kacet N, Mosconi G: A review of teicoplanin in the treatment of serious neonatal infections. Eur J Pediatr 1997; 156: 423-427.
5. Degraeuwe PL, Beuman GH, van Tiel FH, Maertzdorf WJ, Blanco CE: Use of teicoplanin in preterm neonates with staphylococcal late-onset neonatal sepsis. Biol Neonate 1998; 73: 287-294.
6. Fanos V, Verlato G, Dal Moro A, Chiaffoni GP, Padovani EM: Staphylococcus epidermidis isolation and antibiotic resistance in a neonatal intensive care unit. J Chemother 1995; 7: 26-29.
7. Kacet N, Dubos JP, Roussel-Delvallez M, Storme L, Pierrat V, Rousseau S, et al: Teicoplanin and amikacin in neonates with staphylococcal infection. Pediatr Infect Dis 1993; 12: 10-20.
8. Munson DP, Thompson TR, Johnson DE, Rhame FS, Van Drunen N, Ferrieri P: Coagulase-negative staphylococcal septicemia: experience in a newborn intensive care unit. J Pediatr 1982; 101: 602-605.
9. Wilson AP: Comparative safety of teicoplanin and vancomycin. Int J Antimicrob Agents 1998; 10: 143-152.
10. Bassetti D, Cruciani M: Teicoplanin therapy in children: a review. Scand J Infect Dis 1990; 72 (Suppl): 35-37.
11. Almon R, Pezzlo M: Processing and interpretation of blood cultures. In: Clinical Microbiology Procedures Handbook (Isenberg HD, ed). Washington, DC: American Society for Microbiology, 1992; pp1-11.
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. NCCLS document M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
13. Kantar M, Kultursay N, Kutukculer N, Akisu M, Cetingul N, Caglayan S: Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms. Eur J Pediatr 2000; 159: 156-157.
14. Oral R, Akisu M, Kultursay N, Vardar F, Tansug N: Neonatal Klebsiella pneumonia sepsis and imipenem/cilastatin. Indian J Pediatr 1998; 65: 121-129.
15. Campoli-Richards DM, Brogden RN, Faulds D: Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 449-486.
16. Isaacs D, Barfield C, Clothier T, Darlow B, Diplock R, Ehrlich J, et al: Late-onset infections of infants in neonatal units. J Paediatr Child Health 1996; 32: 158-161.
17. Beck-Sague CM, Azimi P, Fonseca SN, Baltimore RS, Powell DA, Bland LA, et al: Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr Infect Dis 1994; 13: 1110-1116.
18. Kralinsky K, Lako J, Dluholucky S, Krcmery V, Jr: Nosocomial staphylococcal meningitis in neonates successfully treated with intraventricular teicoplanin. Chemotherapy 1999; 45: 313-314.
19. Matsubara H, Makimoto A, Higa T, Kawamoto H, Kanda Y, Kami M, et al: Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient. Bone Marrow Transplant 2003; 31: 65-67.
20. Kitajima H: Prevention of methicillin-resistant Staphylococcus aureus infections in neonates. Pediatr Int 2003; 45: 238-245.
21. Anand NK, Gupta AK, Mohan M, Lamba IM, Gupta R, Srivastava L: Coagulase negative staphylococcal septicemia in newborns. Indian Pediatr 1991; 28: 1241-1248.
22. Sunakawa K, Nonoyama M, Fujii R, Iwai N, Sakata H, Shirai M, et al: Pharmacokinetic and clinical studies on teicoplanin for sepsis by methicillin-cephem resistant Staphylococcus aureus in the pediatric and neonate field (abstract). Jpn J Antibiot 2002; 55: 656-677.
23. Wood MJ: The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-222.
24. Fanos V, Mussap M, Khoory BJ, Vecchini S, Plebani M, Benini D: Renal tolerability of teicoplanin in a case of neonatal overdose. J Chemother 1998; 10: 381-384.
25. Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O: Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS). J Am Soc Nephrol 1999; 10: 136-145.